ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646233 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646233; 2) Community: the network communities that were significantly associated with the response to NSC 646233; 3) Molecule: the relationships between components within communities and NSC 646233; 4) MDR: the compounds that were significantly associated with the NSC 646233.

NSC Compound Enrichment Correlation
NSC 709362 Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- 0.00910228844192553 0.093857877
NSC 714636 Null 0.00910228844192553 0.31529116
NSC 718368 Null 0.00910228844192553 0.24297819
NSC 718729 Cyclopent-4-ene-1,3-dione, 2-[[4-hydroxy-3,5-bis(1,1-dimethylethyl)phenyl]methyl]- 0.00910228844192553 0.11609354
NSC 726146 Null 0.00910228844192553 0.17347875
NSC 734913 Null 0.00910228844192553 0.1529928
NSC 76150 Null 0.00910228844192553 0.42704026
NSC 130279 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) 0.0091022884419256 -0.02047892
NSC 135073 WITHACNISTIN 0.0091022884419256 0.30146004
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0091022884419256 0.14821902
Total:82  Current:20    [First] [Prev] [Next] [Last]